CAJ | 학술논문

乳腺癌是我国女性发病率最高的恶性肿瘤之一，传统疗法如化疗、放疗、内分泌疗法等虽延长转移性乳腺癌患者的生存时间，但患者整体预后较差。血管调控学说认为肿瘤远处转移依赖血管调控的失衡，联合或单独应用抗血管生成治疗转移性乳腺癌解一种新思路。本文综述抗血管生成治疗转移性乳腺癌的进展。
유선암시아국녀성발병솔최고적악성종류지일，전통요법여화료、방료、내분비요법등수연장전이성유선암환자적생존시간，단환자정체예후교차。혈관조공학설인위종류원처전이의뢰혈관조공적실형，연합혹단독응용항혈관생성치료전이성유선암해일충신사로。본문종술항혈관생성치료전이성유선암적진전。
Breast cancer is one of the malignant tumors with highest incidence in China, traditional therapies such as chemotherapy, radiotherapy and endocrinotherapy can lengthen survival time of patients with metastatic breast cancer, but the overall prognosis is poor. Vascular control theory re-gards that distant metastasis tumor is due to vascular regulation imbalance, the combined or separate application of anti-angiogenic therapy on meta-static breast cancer is a new method. This paper summarizes the progress of anti-angiogenesis therapy for metastatic breast.